Plasmacytoid dendritic cell depletion in DOCK8 deficiency: Rescue of severe herpetic infections with IFN-? 2b therapy - 29/05/14
Doi : 10.1016/j.jaci.2014.03.032
Sevgi Keles, MD a, b, ∗ 
, Haifa H. Jabara, BSc b, ∗, Ismail Reisli, MD a, Douglas R. McDonald, MD, PhD b, Isil Barlan, MD c, Rima Hanna-Wakim, MD d, Ghassan Dbaibo, MD d, Gerard Lefranc, PhD e, Waleed Al-Herz, MD f, Raif S. Geha, MD b, ‡, Talal A. Chatila, MD, MSc b, ‡
, Haifa H. Jabara, BSc b, ∗, Ismail Reisli, MD a, Douglas R. McDonald, MD, PhD b, Isil Barlan, MD c, Rima Hanna-Wakim, MD d, Ghassan Dbaibo, MD d, Gerard Lefranc, PhD e, Waleed Al-Herz, MD f, Raif S. Geha, MD b, ‡, Talal A. Chatila, MD, MSc b, ‡ a Division of Pediatric Immunology and Allergy, Meram Medical Faculty, Necmettin Erbakan University, Konya, Turkey
b Division of Immunology, Department of Pediatrics, Boston Children's Hospital, Harvard Medical School, Boston, Mass
c Division of Pediatric Allergy and Immunology, Marmara University Faculty of Medicine, Istanbul, Turkey
d Division of Pediatric Infectious Diseases, American University of Beirut, Beirut, Lebanon
e University Montpellier 2 and Institute of Human Genetics, CNRS UPR 1142, Montpellier, France
f Department of Pediatrics, Faculty of Medicine, Kuwait University, Kuwait City, Kuwait
| The work was supported by the National Institutes of Health (grant no. 5R01AI065617 and grant no. 1R21AI087627 to T.A.C. and grant no. 1R01AI100315 to R.S.G. and by the Scientific and Technological Research Council of Turkey (grant no. 1059B191300622 to S.K.). This project has been funded in part by federal funds from the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under contract no: HHSN272201000020C. |
|
| Disclosure of potential conflict of interest: T. A. Chatila and R. S. Geha's institutions have received grant funding from the National Institutes of Health. G. Dbaibo's institution has received funding from the Dubai-Harvard Foundation for Medical Research. The rest of the authors declare that they have no relevant conflicts of interest. |
© 2014
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 133 - N° 6
P. 1753 - juin 2014 Retour au numéro
Article précédent
- Anti-inflammatory and corticosteroid-enhancing actions of vitamin D in monocytes of patients with steroid-resistant and those with steroid-sensitive asthma
- Yong Zhang, Donald Y.M. Leung, Elena Goleva
- The effects of calcitriol treatment in glucocorticoid-resistant asthma
- Alexandra M. Nanzer, Emma S. Chambers, Kimuli Ryanna, Anna T. Freeman, Grainne Colligan, David F. Richards, Peter M. Timms, Adrian R. Martineau, Christopher J. Griffiths, Christopher J. Corrigan, Catherine M. Hawrylowicz
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?